Fox Run Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $651K | Buy |
+13,328
| New | +$651K | 0.11% | 353 |
|
|
2024
Q3 | – | Sell |
-27,997
| Closed | -$856K | – | 1046 |
|
|
2024
Q2 | $856K | Buy |
+27,997
| New | +$856K | 0.16% | 228 |
|
|
2024
Q1 | – | Sell |
-7,415
| Closed | -$204K | – | 1003 |
|
|
2023
Q4 | $204K | Buy |
+7,415
| New | +$204K | 0.05% | 629 |
|
|
2018
Q4 | – | Sell |
-11,017
| Closed | -$518K | – | 681 |
|
|
2018
Q3 | $518K | Sell |
11,017
-987
| -8% | -$46.4K | 0.23% | 166 |
|
|
2018
Q2 | $405K | Buy |
+12,004
| New | +$405K | 0.13% | 326 |
|